期刊文献+

酶化学法测定糖化血红蛋白性能的验证 被引量:7

Verification of the analytical performance of haemoglobin A1c measurements tested by chemico-enzymatic method
暂未订购
导出
摘要 目的对酶化学法测定糖化血红蛋白进行方法学性能的验证。方法参考美国国家临床实验室标准化委员会系列文件和相关文献,结合工作实际对酶化学法测定糖化血红蛋白进行精密度、准确度的分析测量范围和生物参考区间等进行评价,并将实验结果与厂家提供的分析性能或公认的质量指标进行比较。结果批内变异系数(CV)0.87%~1.29%,批间CV1.74%~2.12%;在3.0%~16.0%范围内线性良好Y=1.010X-0.004,r=0.999 7,平均回收率101.37%;该方法与TOSOH G7离子交换高效液相层析法二组比较差异无统计学意义(Y=0.962 2X+0.045,r=0.994 0,P〉0.05);分析测量范围(AMR)验证和生物参考区间验证结果均符合质量要求。结论酶化学法测定糖化血红蛋白主要分析性能符合质量目标要求,适合临床检验科应用。 Objective To verify the analytical performance of haemoglobin A1c(HbA1c) tested by chemico-enzymatic method.Methods Referring to NCCLS evaluation protocols and pertinent literature and based on our practical work,we tested the precision,accuracy,analytical measurements range and biotic interval of HbA1c by chemico-enzymatic method,then compared the result with quality index of the manufacturer or generally accepted.Results The within-run coefficient of variation(CV) was 0.87%-1.29% and between-run CVwas 1.74%-2.12%.The linear correlation coefficient of the method was satisfactory(Y=1.010C-0.004,r=0.999 7) in 3.0%-16.0%,and the average recovery rate was 101.37%.The difference of the coefficient of correlation between enzymatic method and high performance liquid chromatography(HPLC) was significant(Y=0.962 2X+0.045,r=0.994 0,P0.05).The results of the verification for analytical measurements range(AMR) and biotic interval were accorded with the request of the quality.Conclusion The HbA1c measurements for enzymatic method is accorded with the request of the quality,which can be applied on automatic diagnose.
出处 《检验医学与临床》 CAS 2011年第12期1450-1451,1454,共3页 Laboratory Medicine and Clinic
关键词 糖化血红蛋白 酶化学法 性能验证 haemoglobin A1c chemico-enzymatic method verification
  • 相关文献

参考文献9

  • 1International Federation of Clinical Chemistry and Laboratory Medicine,IFCC Scientific Division,Nordin G,et al.Recommendation for term and measurement unit for "HbA1c"[J].Clin Chem Lab Med,2007,45(8):1081-1082.
  • 2American Diabetes Association.Standards of medical care for patients with diabetes mellitus[J].Diabetes Care,2003,26:533.
  • 3毕波,吕元.定量检测方法学性能验证的系统设计[J].中华检验医学杂志,2007,30(2):143-145. 被引量:154
  • 4Clinical and Laboratory Standards Institute.Evaluation of precision performance of quantitative measurement methods[S].EP5-A2,CLSI,2004:80.
  • 5Clinical and Laboratory Standards Institute.Interference testing in clinical chemistry[S].EP7-A2,CLSI,2005:75.
  • 6Clinical and Laboratory Standards Institute.Method comparison and biss estimation using patient samples[S].EP9-A2,CLSI,2002:109.
  • 7Clinical and Laboratory Standards Institute.Evaluation of the linearity of quantitative measurement Procedures[S].EP6-A2,CLSI,2003:75.
  • 8Clinical and Laboratory Standards Institute.How to define and determine reference intervals in the clinical laboratory[S].C28-A2,CLSI,2000:40.
  • 9Krishnamuyti U,Stelfes MW.Glycohemoglobin:a primary predictor of development or reversal of complications of diabetes mellitrick[J].Clin Chem,2001,47(5):1157-1165.

二级参考文献6

  • 1Department of Health and Human Services,Centers for Medicare & Medicaid Services.Clinical laboratory improvement amendments of 1988:final rule.Fed Register,2003:3704.
  • 2NCCLS.EP10-A Preliminary evaluation of quantitative clinical laboratory methods.Wayne PA:National Committee for Clinical Laboratory Standards,1998.
  • 3Spencer CA.Thyroid profiling for the 1990s:free T4 estimate or sensitive TSH measurement.J Clin Immunoassay,1989,12:82-89.
  • 4NCCLS.EP6-P2 Evaluation of linearity of quantitative analytical methods.Proposed guideline-second edition,2002.21-20.
  • 5NCCLS.C28-A2 How to define and determine reference intervals in the clinical laboratory; approved guideline.Wayne PA:NCCLS,2000.
  • 6NCCLS.EP9-A Method comparison and bias estimation using patient samples.Wayne PA:National Committee for Clinical Laboratory Standards,1995.

共引文献153

同被引文献130

引证文献7

二级引证文献53

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部